Clinical Trial Update: A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia or Low-risk Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for SP-420 in transfusion-dependent beta-thalassemia and low-risk myelodysplastic syndromes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndromes

Drugs mentioned

• SP-420

Snippet

Sponsor: Pharmacosmos A/S | Conditions: Beta Thalassemia Major Anemia, Myelodysplastic Syndrome | Phase 2 | Status: RECRUITING